Legislative record

AB 2302STATE · CaliforniaIntroduced

Food safety: infant formula.

Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics, under the administration and enforcement of the State Department of Public Health. A violation of these provisions is punishable as a misdemeanor. This bill would require a manufacturer of infant formula for sale or distribution in this state to test its final infant formula product for arsenic, cadmium, lead, and mercury at least once per month. The bill also would, commencing on January 1, 2028, require a brand owner, as defined, to provide information to consumers on its internet website or package label regarding specific information about its infant formula that includes, among other things, certain test results for arsenic, cadmium, lead, and mercury. The bill would specifically prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state any infant formula that does not comply with these requirements. The bill would require the manufacturer and brand owner to provide test results to the department upon request, as specified. By expanding the requirements relating to infant formula under the Sherman Food, Drug, and Cosmetic Law, the violation of which would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Voted 7/1/2026View source

Roll-call record

How representatives voted

68 yea·0 nay

Docket history

Action history

  1. 7/1/2026In committee: Set, first hearing. Hearing canceled at the request of author.
  2. 6/25/2026From committee: Do pass and re-refer to Com. on E.Q. (Ayes 9. Noes 0.) (June 24). Re-referred to Com. on E.Q.
  3. 6/15/2026From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.
  4. 6/10/2026Referred to Coms. on HEALTH and E.Q.
  5. 5/28/2026In Senate. Read first time. To Com. on RLS. for assignment.
  6. 5/27/2026Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 0.)
  7. 5/19/2026Read second time. Ordered to third reading.
  8. 5/18/2026Read second time and amended. Ordered returned to second reading.
  9. 5/14/2026From committee: Amend, and do pass as amended. (Ayes 12. Noes 0.) (May 14).
  10. 5/14/2026Joint Rule 62(a), file notice suspended. (Page 5030.)